Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib/IIa open-label, multicenter clinical trial of Latanoprost FA SR Ocular Implant.

Next Previous
X
Search
Trial Profile

Phase Ib/IIa open-label, multicenter clinical trial of Latanoprost FA SR Ocular Implant.

Status: Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 03 Nov 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Latanoprost (Primary)
  • Indications Open-angle glaucoma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors PolyActiva

    • Most Recent Events

    • 02 Nov 2023 According to a PolyActiva media release , PolyActiva will present its interim Phase 2a data at the Eyecelerator Ophthalmic Innovation Conference in San Francisco on November 2nd. The company plans to initiate its Phase 2b clinical trial in the US, Australia, and New Zealand in 2024.
    • 02 Nov 2023 According to a PolyActiva media release , Status changed from recruiting to active, no longer recruiting.
    • 02 Nov 2023 According to a PolyActiva media release ,Patient enrolment has now been completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top